LifeStance Health (LFST) Cash from Investing Activities (2020 - 2026)

LifeStance Health (LFST) has 7 years of Cash from Investing Activities data on file, last reported at -$13.9 million in Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at -$13.9 million, down 94.07% year-over-year; the trailing twelve-month figure through Mar 2026 was -$42.9 million (down 81.41% YoY), and the FY2025 annual result was -$36.1 million, down 67.51% from the prior year.
• Cash from Investing Activities slipped to -$13.9 million in Q1 2026 per LFST's latest filing, from -$10.9 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at -$5.1 million in Q3 2024 and troughed at -$50.9 million in Q1 2022.
• A 5-year average of -$16.0 million and a median of -$10.9 million in 2025 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities slumped 329.7% in 2022, then jumped 81.47% in 2024.
• A 5-year view of Cash from Investing Activities shows it stood at -$30.3 million in 2022, then jumped by 62.33% to -$11.4 million in 2023, then soared by 44.8% to -$6.3 million in 2024, then sank by 73.16% to -$10.9 million in 2025, then dropped by 27.5% to -$13.9 million in 2026.
• Business Quant data shows LFST's Cash from Investing Activities at -$13.9 million in Q1 2026, -$10.9 million in Q4 2025, and -$10.3 million in Q3 2025.